Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients

NCT02011841 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped We failed to recruit patients

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG: Rifaximin
DRUG: Ciprofloxacin

Sponsor

Seoul National University Hospital